InvestorsHub Logo

dr_lowenstein

12/06/22 9:13 PM

#544942 RE: SkyLimit2022 #544938

yes it is published . Not as guidance, as Pazdur himself said:

The use of external control arms in oncology is an evolving area of methodological advancement and regulatory interest. Thus far, external control data have been limited to establishing natural history or providing supportive data analyses affording clinical context for an observed treatment effect. These data have not provided pivotal support as substantial evidence of treatment effectiveness in oncology, and therefore have not yet been included in the prescription drug labeling.